NDC 51672-4196

Deferiprone

Deferiprone

Deferiprone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Deferiprone.

Product ID51672-4196_4028eb31-5ba4-4626-9f1c-32e913896561
NDC51672-4196
Product TypeHuman Prescription Drug
Proprietary NameDeferiprone
Generic NameDeferiprone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-02-08
Marketing CategoryANDA / ANDA
Application NumberANDA208800
Labeler NameTaro Pharmaceuticals U.S.A., Inc.
Substance NameDEFERIPRONE
Active Ingredient Strength500 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 51672-4196-1

100 TABLET in 1 BOTTLE (51672-4196-1)
Marketing Start Date2019-02-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51672-4196-1 [51672419601]

Deferiprone TABLET
Marketing CategoryANDA
Application NumberANDA208800
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-08

Drug Details

Active Ingredients

IngredientStrength
DEFERIPRONE500 mg/1

OpenFDA Data

SPL SET ID:5af1643d-4c6e-4668-ae9b-1046f0ad6d8a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 389242
  • UPC Code
  • 0351672419615
  • Pharmacological Class

    • Iron Chelating Activity [MoA]
    • Iron Chelator [EPC]

    NDC Crossover Matching brand name "Deferiprone" or generic name "Deferiprone"

    NDCBrand NameGeneric Name
    0054-0576DeferiproneDeferiprone
    0054-0711DeferiproneDeferiprone
    51672-4196DeferiproneDeferiprone
    10122-100FERRIPROXdeferiprone
    10122-101FERRIPROXdeferiprone
    10122-103FERRIPROXDEFERIPRONE
    10122-104FERRIPROXdeferiprone
    52609-0006FERRIPROXdeferiprone
    52609-0007FERRIPROXdeferiprone
    52609-4502FERRIPROXdeferiprone

    Trademark Results [Deferiprone]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DEFERIPRONE
    DEFERIPRONE
    97303966 not registered Live/Pending
    Beer, Kenneth
    2022-03-09

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.